|
|
| | (3S,4S)-3-Hexyl-4-[(R)-2-(hydroxytridecyl)]oxetan-2-one Basic information |
| Product Name: | (3S,4S)-3-Hexyl-4-[(R)-2-(hydroxytridecyl)]oxetan-2-one | | Synonyms: | (3S,4S)-3-Hexyl-4-[(2R)-2-hydroxytridecyl]-2-oxetanone;Orlistat Related Compound A (25 mg) ((3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone);[3S-[3α,4β(S*)]]-3-Hexyl-4-(2-hydroxytridecyl)-2-oxetanone;Orlistat USP RC A;Orlistat Related CoMpound A;2-Oxetanone,3-hexyl-4-[(2R)-2-hydroxytridecyl]-, (3S,4S)-;Orlistat USP Related Compound A;(3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone | | CAS: | 104872-06-2 | | MF: | C22H42O3 | | MW: | 354.57 | | EINECS: | 418-650-2 | | Product Categories: | | | Mol File: | 104872-06-2.mol | ![(3S,4S)-3-Hexyl-4-[(R)-2-(hydroxytridecyl)]oxetan-2-one Structure](CAS/GIF/104872-06-2.gif) |
| | (3S,4S)-3-Hexyl-4-[(R)-2-(hydroxytridecyl)]oxetan-2-one Chemical Properties |
| Melting point | 61-62 °C | | Boiling point | 467.9±18.0 °C(Predicted) | | density | 0.935 | | storage temp. | Inert atmosphere,Store in freezer, under -20°C | | solubility | Chloroform (Slightly), Methanol (Slightly) | | form | Solid | | pka | 14.71±0.20(Predicted) | | color | White to Off-White | | Major Application | pharmaceutical (small molecule) | | InChI | 1S/C22H42O3/c1-3-5-7-9-10-11-12-13-14-16-19(23)18-21-20(22(24)25-21)17-15-8-6-4-2/h19-21,23H,3-18H2,1-2H3/t19-,20+,21+/m1/s1 | | InChIKey | RSOUWOFYULUWNE-HKBOAZHASA-N | | SMILES | O1[C@H]([C@@H](C1=O)CCCCCC)C[C@H](O)CCCCCCCCCCC |
| Hazard Codes | N | | Risk Statements | 50/53 | | Safety Statements | 60-61 | | HS Code | 2932206000 | | Storage Class | 11 - Combustible Solids |
| | (3S,4S)-3-Hexyl-4-[(R)-2-(hydroxytridecyl)]oxetan-2-one Usage And Synthesis |
| Uses | (3S,4S)-3-Hexyl-4-[(2R)-2-hydroxytridecyl]-2-oxetanone is an analog of Tetrahydrolipstatin, an inhibitor of the hydrolysis of endocannabinoid 2-arachidonoylglycerol (2-AG), also an intermediate in the
preparation of Orlistat (O686500). | | Uses | (3S,4S)-3-Hexyl-4-[(2R)-2-hydroxytridecyl]-2-oxetanone (Orlistat USP Related Compound A) is an analog of Tetrahydrolipstatin, an inhibitor of the hydrolysis of endocannabinoid 2-arachidonoylglycerol (2-AG), also an intermediate in the preparation of Orlistat (O686500). |
| | (3S,4S)-3-Hexyl-4-[(R)-2-(hydroxytridecyl)]oxetan-2-one Preparation Products And Raw materials |
|